Quantum computing is poised to unlock trillion-dollar opportunities in medicine, finance, and AI.
IonQ's revenue is growing rapidly at 82% year over year, and the company holds over $1.6 billion in cash.
Substantial financial losses and an extremely high valuation make IonQ a highly speculative investment.
For decades, quantum computing has felt like a technology that's perpetually just around the corner. Unlike failed promises of the past, however, quantum machines are now a reality, crunching numbers in university labs and tech-giant data centers. The question is not if quantum computing works, but when it will become commercially valuable.
For IonQ (NYSE: IONQ), the first pure-play quantum company on the public market, that timeline will determine if today's stock is tomorrow's big winner or a cautionary tale about investing too early in transformative tech.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
Image source: Getty Images.
Market projections are staggering. McKinsey estimates quantum computing could generate $1.3 trillion in value by 2040, a figure echoed by other major analysts. This isn't about incremental improvements; quantum computers are designed to solve problems that would take classical machines millions of years.
Imagine pharmaceutical companies precisely modeling protein folding to create new drugs, financial firms optimizing global portfolios in real time, or logistics companies routing supply chains with perfect efficiency. The technology's power comes from qubits, which can exist in multiple states at once, allowing for the parallel processing of an exponential number of calculations.
While tech giants focus on superconducting qubits, IonQ has chosen a different path: trapped-ion technology. By trapping individual atoms in electromagnetic fields, IonQ achieves an industry-leading 99.8% two-qubit gate fidelity. This extreme accuracy is critical, as quantum errors compound exponentially.
The strategy is showing early signs of success. The company reported $20.7 million in Q2 2025 revenue, an 81.5% increase year over year, and raised its full-year guidance to between $82 million and $100 million. Major clients like Hyundai, Airbus, and GE Research are already using IonQ's systems.
By integrating with cloud platforms like Amazon's AWS, Microsoft Azure, and Alphabet's Google Cloud, IonQ is embedding its technology directly into existing enterprise workflows. The company holds over $1.6 billion in cash after completing a $1 billion equity offering, providing a substantial runway for growth investments and strategic acquisitions.
Despite its technical promise, IonQ operates with significant losses, posting a net loss of $177.5 million in the second quarter alone. With a $12 billion market cap, the company trades at nearly 140 times its forward revenue guidance, a valuation that prices in success that may never materialize.
Competition is also fierce. IBM already offers 1,000-qubit systems, PsiQuantum is promising million-qubit machines by 2030, and Alphabet's latest chips boast breakthrough error correction. Beyond direct rivals, there's a fundamental uncertainty.
No one knows which quantum architecture will ultimately win. IonQ could execute its strategy perfectly and still be rendered obsolete if another technology proves more scalable. That's a real risk potential shareholders shouldn't brush off lightly.
An investment in IonQ depends on two critical factors: the commercial timeline of quantum computing and the long-term viability of trapped-ion architecture. The company pairs legitimate technology leadership with immense financial losses and unproven economics.
For an investor with a high tolerance for risk, IonQ offers asymmetric upside. The stock could multiply in value if quantum computing delivers on its promise by 2030. The key is prudent position sizing. A small allocation of 1% to 2% of a portfolio could capture the potential gains while limiting the downside.
Think of IonQ as you would a biotech company before its first blockbuster drug. While most experimental drugs fail, the winners can generate a 100-fold return. Quantum computing may follow a similar path, rewarding the early believers who backed the eventual winner in a race that has just begun.
Before you buy stock in IonQ, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and IonQ wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $661,220!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,114,162!*
Now, it’s worth noting Stock Advisor’s total average return is 1,069% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of August 25, 2025
George Budwell has positions in IonQ and Microsoft. The Motley Fool has positions in and recommends Alphabet, Amazon, International Business Machines, and Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.